Associations between prenatal maternal urinary concentrations of personal care product chemical biomarkers and childhood respiratory and allergic outcomes in the CHAMACOS study
- PMID: 30293015
- PMCID: PMC6239199
- DOI: 10.1016/j.envint.2018.09.027
Associations between prenatal maternal urinary concentrations of personal care product chemical biomarkers and childhood respiratory and allergic outcomes in the CHAMACOS study
Abstract
Background: Personal care product chemicals may be contributing to risk for asthma and other atopic illnesses. The existing literature is conflicting, and many studies do not control for multiple chemical exposures.
Methods: We quantified concentrations of three phthalate metabolites, three parabens, and four other phenols in urine collected twice during pregnancy from 392 women. We measured T helper 1 (Th1) and T helper 2 (Th2) cells in their children's blood at ages two, five, and seven, and assessed probable asthma, aeroallergies, eczema, and lung function at age seven. We conducted linear and logistic regressions, controlling for additional biomarkers measured in this population as selected by Bayesian Model Averaging.
Results: The majority of comparisons showed null associations. Mono-n-butyl phthalate (MnBP) was associated with higher Th2% (RR: 10.40, 95% CI: 3.37, 17.92), and methyl paraben was associated with lower Th1% (RR: -3.35, 95% CI: -6.58, -0.02) and Th2% at borderline significance (RR: -4.45, 95% CI: -8.77, 0.08). Monoethyl phthalate was associated with lower forced expiratory flow from 25 to 75% of forced vital capacity (FEF25-75%) (RR: -3.22 L/s, 95% CI: -6.02, -0.34). Propyl paraben (OR: 0.86, 95% CI: 0.74, 0.99) was associated with decreased odds of probable asthma.
Conclusions: While some biomarkers, particularly those from low molecular weight phthalates, were associated with an atopic cytokine profile and poorer lung function, no biomarkers were associated with a corresponding increase in atopic disease.
Keywords: Allergy; Asthma; Chemical mixtures; Cytokines; Personal care products; Phthalates.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declarations of interest: none
References
-
- Akinbami LJ; Moorman JE; Garbe PL; Sondik EJ Status of childhood asthma in the United States, 1980–2007. Pediatrics 2009;123:S131–S145 - PubMed
-
- Asher MI; Keil U; Anderson HR; Beasley R; Crane J; Martinez F; Mitchell EA; Pearce N;Sibbald B; Stewart AW; et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995;8:483–491 - PubMed
-
- Asher MI; Montefort S; Björkstén B; Lai CK; Strachan DP; Weiland SK; Williams H; Group I.P.T.S. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. The Lancet 2006;368:733–743 - PubMed
-
- Ashley-Martin J; Dodds L; Levy AR; Platt RW; Marshall JS; Arbuckle TE Prenatal exposure to phthalates, bisphenol A and perfluoroalkyl substances and cord blood levels of IgE, TSLP and IL-33. Environmental research 2015;140:360–368 - PubMed
